CHEN Miao,DU Xiaoli,FENG Yahong,et al.Effect of Jianpi Yishen Huazhuo Prescription on Ovarian Function in Rats with Polycystic Ovary Syndrome Based on NLRP3 Inflammatory Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(20):61-70.
CHEN Miao,DU Xiaoli,FENG Yahong,et al.Effect of Jianpi Yishen Huazhuo Prescription on Ovarian Function in Rats with Polycystic Ovary Syndrome Based on NLRP3 Inflammatory Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(20):61-70. DOI: 10.13422/j.cnki.syfjx.20221942.
Effect of Jianpi Yishen Huazhuo Prescription on Ovarian Function in Rats with Polycystic Ovary Syndrome Based on NLRP3 Inflammatory Pathway
To explore the mechanism of Jianpi Yishen Huazhuo prescription in the improvement of ovarian function in polycystic ovary syndrome (PCOS).
Method
2
Seventy female SD rats in SPF grade were randomly divided into 6 groups, 15 in the blank group and 15 in the model group, 10 in the metformin group (0.1 g·kg
-1
·d
-1
), and 10 in the low (1.275 g·kg
-1
·d
-1
), medium (2.55 g·kg
-1
·d
-1
), and high-dose (5.10 g·kg
-1
·d
-1
) Jianpi Yishen Huazhuo prescription groups. The blank group was given normal saline (10 mL·kg
-1
·d
-1
) by gavage and ordinary feed, and the other groups were given letrozole (1 mg·kg
-1
·d
-1
) by gavage combined with high-fat feed for 21 days to induce the model of PCOS. After modeling, the blank group and model group were given equal volume normal saline by gavage, and each drug group was given the corresponding dose of the drug by gavage for 30 days. The changes in body mass and fasting blood glucose (FPG) of rats before and after modeling were compared. Hematoxylin eosin (HE) staining was used to observe the morphological change in the ovaries of rats in each group. The serum levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T), anti-Mullerian hormone (AMH), and estradiol (E
2
) were measured by enzyme-linked immunosorbent assay (ELISA), and the LH/FSH ratio was calculated. Immunohistochemical staining (IHC) and Western blot were used to detect the protein expression levels of nucleoside binding oligomerization domain protein like receptor 3 (NALP3), apoptosis-associated speck-like protein (ASC), cysteine protease-1 (Caspase-1), nuclear transcription factor-
κ
B (NF-
κ
B), interleukin-1
β
(IL-1
β
), interleukin-18 (IL-18), and interleukin-6 (IL-6) in the rat ovaries.
Result
2
As compared with the blank group, large follicles with polycystic expansion were found in the ovaries of the model group, no dominant follicles were found, the granular layer of follicles decreased and arranged loosely, and the number of corpus luteum decreased significantly. Serum T, LH, AMH and LH/FSH increased in the model group (
P
<
0.05,
P
<
0.01), while FSH and E
2
decreased (
P
<
0.05,
P
<
0.01). The relative protein expression levels of NALP3, ASC, Caspase-1, NF-
κ
B, IL-1
β,
IL-18, and IL-6 increased (
P
<
0.05,
P
<
0.01) in the ovaries of the model group. Compared with the model group, the low, medium, and high-dose Jianpi Yishen Huazhuo prescription groups and the metformin group showed growing follicles and corpus luteum at all levels, the number of cystic expanding follicles decreased, the thickness of follicular granular layer increased, the number of follicular fluid increased, mature follicles were visible, and the local morphology of oocytes was complete. Serum T, LH, AMH, and LH/FSH in these groups decreased (
P
<
0.05,
P
<
0.01), while E
2
and FSH increased (
P
<
0.05). The relative protein expressions of NALP3, ASC, Caspase-1, NF-
κ
B, IL-1
β
,
IL-18, and IL-6 in the ovaries of these groups decreased (
P
<
0.05,
P
<
0.01). There was no significant difference among the treatment groups.
Conclusion
2
By inhibiting the activation of NLRP3 inflammasome, Jianpi Yishen Huazhuo prescription reduces the release of NALP3, ASC, Caspase-1, NF-
κ
B, IL-18, IL-1
β
, and IL-6 inflammatory factors in ovarian tissues, regulates endocrine level, and effectively reduces PCOS inflammatory statu, so as to play a role in improving ovarian function.
HERMAN R , JENSTERLE M , JANEŽ A , et al . Genetic variability in antioxidative and inflammatory pathways modifies the risk for PCOS and influences metabolic profile of the syndrome [J]. Metabolites , 2020 , 10 ( 11 ): 439 .
ENGIN A . The pathogenesis of obesity-associated adipose tissue inflammation [J]. Adv Exp Med Biol , 2017 , 960 : 221 - 245 .
ZHUANG Z , PAN X , ZHAO K , et al . The effect of interleukin-6 (IL-6), interleukin-11 (IL-11), signal transducer and activator of transcription 3 (STAT3), and Akt signaling on adipocyte proliferation in a rat model of polycystic ovary syndrome [J]. Med Sci Monit , 2019 , 26 ( 25 ): 7218 - 7227 .
POPOVIC M , SARTORIUS G , CHRIST-CRAIN M . Chronic low-grade inflammation in polycystic ovary syndrome:Is there a (patho)-physiological role for interleukin-1? [J]. Semin Immunopathol , 2019 , 41 ( 4 ): 447 - 459 .
WANG D , WENG Y , ZHANG Y , et al . Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice [J]. Sci Total Environ , 2020 , doi: 10.1016/j.scitotenv.2020.141049 http://dx.doi.org/10.1016/j.scitotenv.2020.141049 .
HERMAN R , JENSTERLE M , JANEŽ A , et al . Genetic variability in antioxidative and inflammatory pathways modifies the risk for PCOS and influences metabolic profile of the syndrome [J]. Metabolites , 2020 , 10 ( 11 ): 439 .
Mechanism of Kidney-tonifying and Liver-regulating Cyclical Therapy and Formula in Improving Endometrial Receptivity during "Implantation Window" in Rats with Polycystic Ovary Syndrome via miR-140-5p/VEGF Pathway
Mechanism of Modified Guishenwan in Regulating AMPK/Akt/Nrf2 Pathway to Improve Glucose and Lipid Metabolism and Oxidative Stress in Polycystic Ovary Syndrome Rats
Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway
Intervention Effect of Suanzaoren Tang on Depression Model Rats Based on JNK/c-Myc/p53 Pathway
Signaling Pathways Related to Polycystic Ovary Syndrome and Regulation by Traditional Chinese Medicine: A Review
Related Author
LIU Quan
HE Yiqing
ZHANG Ying
WANG Xi
YANG Shuo
TIAN Jiayu
QIN Wenyi
YANG Juan
Related Institution
Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, Hunan University of Chinese Medicine
Hunan University of Chinese Medicine
The First Affiliated Hospital of Chongqing Medical University
Heilongjiang University of Chinese Medicine
Graduate School of Heilongjiang University of Chinese Medicine